Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe screenshots show only minor formatting adjustments and small copy edits across the page. There are no changes to the core study data such as the title, identifiers, eligibility criteria, outcomes, enrollment, or locations.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference1%

- Check45 days agoChange DetectedAdded a new version label (v3.1.0) and removed several safety-focused topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs), indicating a shift in page scope away from those subjects.SummaryDifference0.2%

- Check59 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the removal of outdated location references. Notably, the total number of study locations has decreased from 96 to 93.SummaryDifference8%

Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.